ARCHIVES

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 41 | November 4, 2011

Download PDF Visit The Full Archive

Related Articles

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

ONS elects Officers, Presents Awards

June 4, 1993

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991

In This Issue: The controversy Over “Cancer Undefeated”

June 6, 1997

Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments

April 19, 2013

Letter to the Editors: Scientists, Media Shouldn’t Overstate “Breakthroughs”

May 29, 1998